Get the Stockscreener App
10.56
4.66%
0.47
Daxor Corporation stock is traded at $10.56, with a volume of 8,607.
It is up +4.66% in the last 24 hours and up +13.67% over the past month.
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
See More
Previous Close:
$10.09
Open:
$10.05
24h Volume:
8,607
Relative Volume:
0.33
Market Cap:
$50.84M
Revenue:
$2.61M
Net Income/Loss:
$1.69M
P/E Ratio:
35.16
EPS:
0.3003
Net Cash Flow:
-
1W Performance:
+5.92%
1M Performance:
+13.67%
6M Performance:
+49.79%
1Y Performance:
+17.33%
1-Day Range:
$10.05
$10.96
1-Week Range:
$9.5309
$11.21
52-Week Range:
$6.55
$11.21
Daxor Corporation Stock (DXR) Company Profile
Name
Daxor Corporation
Sector
Industry
Phone
212-330-8500
Address
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
10.51 | 49.72M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
476.00 | 168.51B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
193.15 | 55.46B | 21.39B | 1.59B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
84.95 | 42.41B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
285.26 | 41.63B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
239.78 | 17.33B | 2.90B | 467.20M | 306.90M | 6.37 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-19 | Initiated | Ascendiant Capital Markets | Buy |
Daxor Corporation Stock (DXR) Latest News
Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available - GlobeNewswire
Revolutionary Hand-Held Blood Volume Analyzer Gets FDA Green Light: Daxor's Game-Changing Medical Innovation - Stock Titan
Financial Survey: DaVita (NYSE:DVA) vs. Daxor (NASDAQ:DXR) - Defense World
Will Daxor Corporation stock recover after recent dropHistorical Volatility and Pattern Breakdown Analysis - Newser
How high can Daxor Corporation stock price go in 2025Free Fast Return Equity Trade Forecast - Newser
Published on: 2025-08-12 05:36:50 - Newser
Using economic indicators to assess Daxor Corporation potentialWeekly Stock Market Strategy Summary - Newser
How Daxor Corporation stock performs during market volatilityLong Term Stock Growth Plan Suggestions - Newser
What’s the recovery path for long term holders of Daxor CorporationRisk-Managed Strategy Based on Price Analysis - Newser
Will Daxor Corporation continue its uptrendSwing Entry Risk Mitigation with Chart Analysis - Newser
Can volume confirm reversal in Daxor CorporationFree Stock Selection With High Accuracy - Newser
Key resistance and support levels for Daxor CorporationFree Target Return Focused Trade Insights - Newser
Why Daxor Corporation stock attracts strong analyst attentionPrice Movement and Market Sentiment Analysis - Newser
Applying chart zones and confluence areas to Daxor CorporationFree Capital Preserving Trade Plan Templates - Newser
Daxor Corporation Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Low Capital High Return Stock Plans - Newser
Chart based analysis of Daxor Corporation trendsYearly Trend Summary and Opportunity Breakdown - Newser
What makes Daxor Corporation stock price move sharplySmart Money Strategy for Growth Stocks - Newser
Daxor Corporation Rings the Closing Bell - Nasdaq
Applying Wyckoff theory to Daxor Corporation stockCapital Safe Picks with Consistent Gains - Newser
Identifying reversal signals in Daxor CorporationSwing Trade Picks with High Potential - Newser
Tick level data insight on Daxor Corporation volatilityLong-Term Growth Trend Summary With Confidence - Newser
Daxor Corporation shares rise 4.40% intraday after FDA clearance for new Blood Volume Analyzer. - AInvest
Daxor (NASDAQ: DXR) Stock Rises After FDA Clears Breakthrough Blood Volume Analyzer for Clinical Care | DXR Stock Price - paginasiete.bo
Daxor Gains FDA Clearance for Blood Volume Analyzer - TipRanks
Daxor receives FDA clearance for next-gen blood volume analyzer By Investing.com - Investing.com Nigeria
Daxor stock soars after FDA clearance for new blood volume analyzer By Investing.com - Investing.com South Africa
Daxor stock soars after FDA clearance for new blood volume analyzer - Investing.com Nigeria
Daxor Corporation Announces FDA Clearance for Revolutionary Blood Volume Analyzer to Improve Patient Outcomes - Quiver Quantitative
Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System - GlobeNewswire
Breakthrough: FDA Approves Game-Changing Blood Volume Analyzer That Cuts Mortality by 86% - Stock Titan
Has Daxor Corporation found a price floorPre-Market Stock Movement Summary and Review - Newser
Is Daxor Corporation a candidate for recovery playFree Short Term Buy Zone Stock Alerts - Newser
Technical signs of recovery in Daxor CorporationTrading Watchlist with Real Time Filters - Newser
What the charts say about Daxor Corporation todaySwing Watchlist With Tight Stop Placement - Newser
Daxor Corporation Stock (DXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.05%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):